X-Therma's Latest News
Read the latest news about X-Therma, Cryopreservation and Biopreservation.
Chemically Defined, Safe And Effective Cryopreservation
XT-Thrive® contains fully synthetic biomimetics (peptoids) which are non-toxic, and prevent harmful ice crystal formation in cells at temperatures down to-196°C. Under polarized light ice
A Wonderful Celebration of Our Seventh Anniversary
What a wonderful celebration of the 7th anniversary we had on Halloween weekend! We truly appreciate the commitment and contribution of our dedicated team and
Reducing Adverse Events And Improving Outcomes During And After Cell and Gene Therapy With DMSO-Free, Non-Toxic Cryopreservation
Cryopreservation for cell and gene therapies has long been a crucial consideration for drug developers and manufacturers. These modalities require unique formulation approaches in order
From Arctic Fish To New Cell Therapy Preservation Technologies
Cryopreservation should maintain the function and viability of organs and cell therapies, but the process is riddled with challenges. Can nature-inspired proteins make a difference?
Improving Health Equity Through Worldwide Organ Sharing
The organ transplantation field has experienced numerous barriers which have contributed to the creation of organ accessibility issues worldwide. To help tackle these challenges, X-Therma
Emerging Therapies Face Development Hurdles
While traditional biologics continue to see strong market demand, the need for emerging therapies, such as regenerative medicines, has also given rise to a burgeoning
X-Therma Receives FDA Breakthrough Device Designation for XT-ViVo® Preservation Solution and TimeSeal® Organ Transport Device
X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – announced today that The Center for Devices and Radiological Health (CDRH)
X-Therma Brings Biomimetics to Bioprocessing
In the past two years, the cold chain turned into one of the most talked-about aspects of healthcare. Biotechnology company X-Therma in Richmond, CA, plans
Preserving Cell and Gene Therapies Without Using Toxins
Every day it seems you can find a headline somewhere describing the extraordinary progress scientists have made in developing cell and gene therapies for rare